| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Brennan John Owen serves as a Director at IBRX. Across recent SEC filings that breaks down to 3 buys and 0 sells. Those positions are worth an estimated $69K at current prices.
The biggest single holding is IBRX (~$69K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 25,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 2, 2023 | IBRX Immunitybio, Inc. | Director | Buy | 25,000 | $2.83 | $70,700.00 | New | -41.9% | +131.8% |